What GLP-1 Does TRICARE Cover in 2026?
Published: · Last updated:
By The RX Index Editorial Team · Last verified: June 2026
If you're asking what GLP-1 does TRICARE cover, here's the straight answer: it depends on why you're taking it. For weight loss, TRICARE covers Wegovy, Zepbound, and Saxenda — but only on TRICARE Prime, Select, and the premium-based plans, and only after a prior authorization is approved. For type 2 diabetes, TRICARE covers Ozempic, Mounjaro, Trulicity, and Victoza. The catch most people miss: Ozempic and Mounjaro are not covered for weight loss without a diabetes diagnosis.
That one rule — the drug has to match your diagnosis — is where almost every TRICARE denial comes from. Below we'll show you exactly which drug is covered for your situation, what it'll cost in 2026, the prior-authorization requirements, and what to do if the answer is "no." We pulled the actual TRICARE coverage pages and the current prior-authorization form so you don't have to open ten tabs.
This page is for you if:
You have TRICARE Prime, Prime Remote, US Family Health Plan, Select, TRICARE Young Adult, Reserve Select, Retired Reserve, or CHCBP, and you want to know which GLP-1 you can actually get covered before your provider files paperwork.
Not for you if:
You're hoping Ozempic or Mounjaro gets covered for weight loss with no diabetes (it won't), or you have TRICARE For Life and want a weight-loss drug (you're excluded — see the TFL section).
The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.
Quick answer by situation
| If your prescription is for… | The covered GLP-1 to check | First thing to confirm |
|---|---|---|
| Weight loss | Wegovy, Zepbound, or Saxenda | Are you on Prime, Select, or a premium-based plan? |
| Type 2 diabetes | Ozempic, Mounjaro, Trulicity, or Victoza | Does your record show the diagnosis (and metformin history)? |
| Sleep apnea + obesity | Zepbound (its own approved path) | Do you have a sleep study showing AHI 15 or higher? |
| Weight loss — but you're TRICARE For Life / direct-care / NATO | Not covered since Aug 31, 2025 | Check the cash-pay and Medicare Bridge options below |
Sorts your TRICARE, FDA-approved, and cash-pay options in 60 seconds.
The TRICARE GLP-1 Coverage Matrix (2026)
Built by combining TRICARE's official coverage pages, the Express Scripts pharmacy rules, and the live Wegovy/Zepbound prior-authorization form (dated April 10, 2026).
| Medication | TRICARE covers for… | Will not cover for… | What you need | Your 2026 cost if covered |
|---|---|---|---|---|
| Wegovy (semaglutide) injection | Weight management | Type 2 diabetes (use a diabetes GLP-1) | Network-provider Rx + prior authorization + clinical criteria | Active duty $0; most others $44–$85 per fill |
| Zepbound (tirzepatide) | Weight management AND moderate-to-severe sleep apnea in adults with obesity | Type 2 diabetes (use Mounjaro) | Same as above; sleep-apnea path needs documented AHI of 15+ | Same copay structure |
| Saxenda (liraglutide) | Weight management | Excluded groups (TFL, direct care, NATO) | Rx + prior authorization + medical-necessity form | Same copay structure |
| Ozempic (semaglutide) | Type 2 diabetes only | Weight loss without diabetes | Prior authorization + medical-necessity form | Standard diabetes cost-share (unchanged) |
| Mounjaro (tirzepatide) | Type 2 diabetes only | Weight loss without diabetes | Prior authorization + medical-necessity form | Standard cost-share (check your tier) |
| Trulicity (dulaglutide) | Type 2 diabetes only | Weight loss | PA waived if another diabetes drug in TRICARE record within 720 days | Lower copay tier than Ozempic/Mounjaro |
| Victoza (liraglutide) | Type 2 diabetes only | Weight loss | Prior authorization + medical-necessity form | Standard cost-share |
| Rybelsus (oral semaglutide) | Type 2 diabetes (oral option) | Weight loss; under age 18 | Prior authorization; age 18+; diabetes diagnosis | Check the Formulary Search Tool |
| Wegovy pill / Foundayo (newest) | Newer FDA approvals — status may still be settling | — | Confirm on the Formulary Search Tool | Confirm on the Formulary Search Tool |
| Compounded semaglutide / tirzepatide | Not an FDA-approved drug; no verified TRICARE-covered path found | — | — | Treat as cash-pay only |
Sources: TRICARE FAQ (updated Nov 2025); TRICARE Weight Loss Products page (updated Dec 2025); Express Scripts TRICARE GLP-1 FAQ; the TRICARE Wegovy–Zepbound prior-authorization form (April 10, 2026). Newer products and your exact copay tier should be confirmed on the TRICARE Formulary Search Tool.
Not sure which row is you? The RX Index's matcher sorts your TRICARE, FDA-approved, and cash-pay options in about 60 seconds and builds a checklist for your exact plan and diagnosis.
Find My GLP‑1 Path →What GLP-1 does TRICARE cover for weight loss vs. diabetes?
TRICARE splits GLP-1 coverage into two buckets: weight management and type 2 diabetes. For weight management, the covered GLP-1s are Wegovy, Zepbound, and Saxenda. For type 2 diabetes, the covered GLP-1s are Ozempic, Mounjaro, Trulicity, and Victoza. Zepbound also has a third path — moderate-to-severe sleep apnea in adults with obesity — because the FDA approved it for that use in December 2024.
TRICARE doesn't cover a drug just because the FDA approved it. Coverage depends on the approved use, your plan, medical necessity, and whether the drug is on the formulary. The prior-authorization form asks why you're taking the drug, and the "why" has to match what the drug is approved for.
Weight-loss GLP-1s
- Wegovy (semaglutide) — weekly injection
- Zepbound (tirzepatide) — also for sleep apnea
- Saxenda (liraglutide) — daily; needs MN form
Diabetes GLP-1s
- Ozempic (semaglutide)
- Mounjaro (tirzepatide)
- Trulicity (dulaglutide)
- Victoza (liraglutide)
Not covered
- Compounded semaglutide or tirzepatide
- Any GLP-1 used for a non-approved reason
The August 2025 changes did not touch diabetes coverage, and the copays for diabetes drugs didn't change. The diabetes GLP-1 path is still fully open.
Does TRICARE cover Wegovy?
Yes — TRICARE covers Wegovy for weight management on eligible plans (Prime, Select, and premium-based plans) when you meet the clinical criteria and your provider gets a prior authorization approved. The established path is the Wegovy injection; the newer Wegovy pill is FDA-approved, but confirm its exact TRICARE formulary status and copay on the Formulary Search Tool before you count on it.
- It's a weight-management drug, not a diabetes drug.
- There's an adult path (BMI 30+, or 27–29 with a weight-related condition) and a separate adolescent path for ages 12–17 (Wegovy injection only, BMI at or above the 95th percentile for age and sex).
- The Wegovy pill appears on the current prior-authorization form, but tablet coverage, dose, and copay can differ from the injection — look it up on the Formulary Search Tool before assuming.
Does TRICARE cover Zepbound?
Yes — TRICARE covers Zepbound for weight management on eligible plans with prior authorization, and it also has a separate coverage path for moderate-to-severe obstructive sleep apnea in adults with obesity. Zepbound is the only GLP-1 the FDA approved for sleep apnea (approved December 2024), which gives some people a second way in.
- For weight loss, Zepbound follows the same adult criteria as Wegovy (BMI, six months of diet effort, and a step-therapy trial — covered in detail below).
- For sleep apnea, the form asks for the Zepbound Pen Injector, age 18+, a documented AHI of 15 or more events per hour, and a BMI of 30 or higher, plus six months of diet and lifestyle effort. It does not ask you to try the cheaper weight-loss pills first.
- Zepbound is the weight-loss/sleep-apnea tirzepatide. Its diabetes twin is Mounjaro. Submit the wrong one for the wrong reason and you'll get a denial.
Does TRICARE cover Ozempic or Mounjaro for weight loss?
No. TRICARE covers Ozempic and Mounjaro only for type 2 diabetes — not for weight loss. The official prior-authorization form is blunt about it: a GLP-1 that's FDA-approved only for diabetes can't be covered for weight loss without a diabetes diagnosis.
The twin-drug distinction that trips everyone up
- Ozempic and Wegovy both contain semaglutide — but Ozempic is approved for diabetes, Wegovy for weight loss. TRICARE pays based on the product and its approved use.
- Mounjaro and Zepbound both contain tirzepatide — Mounjaro is the diabetes label, Zepbound is the weight-loss (and sleep-apnea) label.
If your goal is weight loss and you don't have diabetes, asking for Ozempic is the slow road. Ask for the right product for your goal.
Why did my doctor or pharmacy say TRICARE won't cover GLP-1?
Usually it's a half-truth, not the whole story. Here's what's really happening when you hear "not covered":
- Wrong product for the goal (Ozempic/Mounjaro for weight loss). Switch to Wegovy or Zepbound.
- Wrong plan. TRICARE For Life and direct-care-only members lost weight-loss coverage in August 2025. Diabetes coverage still works.
- No prior authorization on file yet. "Coverage review required" means the paperwork hasn't been done — not that you're denied.
- Missing documentation (your BMI history, a six-month diet record, or a prior medication you tried).
Which TRICARE plans cover GLP-1 weight-loss drugs?
TRICARE covers weight-loss GLP-1s (Wegovy, Zepbound, Saxenda) for people on TRICARE Prime, Select, and the premium-based plans — when you meet the clinical criteria, get the prescription from a network provider, and have an approved prior authorization. TRICARE For Life, direct-care-only members, and those with NATO or Partnership-for-Peace status are excluded as of August 31, 2025.
| Your plan | Weight-loss GLP-1 covered? | Notes |
|---|---|---|
| TRICARE Prime | ✅ Yes, if criteria met | Network provider + prior authorization; Prime needs a PCM referral to an outside provider |
| TRICARE Prime Remote / Prime Overseas | ✅ Yes, if criteria met | Same rules; some overseas fill differences |
| US Family Health Plan | ✅ Yes, if criteria met | Uses its own designated pharmacy network |
| TRICARE Select (and Select Overseas) | ✅ Yes, if criteria met | Network provider + prior authorization |
| TRICARE Young Adult (Prime or Select) | ✅ Yes, if criteria met | Confirm your plan type |
| TRICARE Reserve Select | ✅ Yes, if criteria met | Premium-based plan |
| TRICARE Retired Reserve | ✅ Yes, if criteria met | Premium-based plan |
| Continued Health Care Benefit Program (CHCBP) | ✅ Yes, if criteria met | Premium-based plan |
| TRICARE For Life | ❌ No (weight-loss drugs) | Diabetes GLP-1s still covered for diabetes |
| Direct care only (space-available at military clinics) | ❌ No (weight-loss drugs) | Full cost for weight-loss drugs |
| NATO / Partnership for Peace status | ❌ No (weight-loss drugs) | Excluded by the 2025 change |
What does TRICARE require to approve Wegovy or Zepbound?
A TRICARE prior authorization for Wegovy or Zepbound isn't a rubber stamp. In general, you need a BMI of 30 or higher (or 27–29 with a weight-related condition), about six months of documented diet and lifestyle effort, and proof you tried a cheaper weight-loss medication first.
The adult weight-loss checklist (Wegovy or Zepbound)
Bring proof of all of these to your provider:
- ✓You're on an eligible plan (Prime, Select, or premium-based).
- ✓A TRICARE network or military provider examined you and built a treatment plan, and billed TRICARE for the visit.
- ✓BMI of 30+, or 27–29 with at least one weight-related condition (diabetes, sleep apnea, high blood pressure, high cholesterol, metabolic syndrome).
- ✓At least six months of documented diet and lifestyle changes that didn't hit your goal.
- ✓You tried about three months of a low-cost generic weight-loss pill — phentermine, phendimetrazine, diethylpropion, or benzphetamine — and didn't lose at least 5% of your weight, or you have a documented reason you can't take one.
- ✓You're not pregnant; not taking another GLP-1 at the same time; no personal or family history of medullary thyroid cancer or MEN2.
The Zepbound sleep-apnea path — a different door in
Because sleep apnea is its own medical condition, Zepbound has a separate coverage path that doesn't require the step-therapy generic trial. To use it, the form asks for:
- The Zepbound Pen Injector (Wegovy doesn't qualify on this path).
- An adult (18+).
- Moderate-to-severe sleep apnea, documented with an AHI of 15 or more events per hour.
- A BMI of 30 or higher.
- Six months of documented diet and lifestyle effort.
How much does a TRICARE-covered GLP-1 cost in 2026?
If you're active duty, covered GLP-1s cost $0. Most other beneficiaries pay a standard pharmacy copay. For 2026, brand-name drugs run $44 for a 90-day mail-order fill or $48 for a 30-day retail fill, and up to $85 if your drug is non-formulary. These copays are locked in for 2026 and 2027.
| Where you fill it | Generic | Brand-name | Non-formulary |
|---|---|---|---|
| Military pharmacy (up to 90-day) | $0 | $0 | Generally not available without MN |
| TRICARE home delivery (up to 90-day) | $14 | $44 | $85 |
| Retail network pharmacy (up to 30-day) | $16 | $48 | $85 |
| Active-duty service members | $0 | $0 | $0 |
- Some beneficiaries pay even less. Active-duty family members on TRICARE Prime Remote in the U.S. pay $0 at home delivery and retail (as of Feb. 28, 2026). Survivors and medically retired families keep frozen, lower rates — for example, $0 generic / $20 brand / $49 non-formulary by mail.
- GLP-1 weight-loss drugs are brand-only. Wegovy and Zepbound have no generic, so you'll pay the brand tier ($44 mail / $48 retail) or the non-formulary tier ($85).
- Home delivery is usually cheapest for 90-day fills. A 90-day brand fill ($44) beats three 30-day retail fills ($144).
Source: TRICARE Pharmacy Costs (2026-2027 schedule, updated April 2026).
Where can you fill a TRICARE-covered GLP-1?
For approved weight-management GLP-1s, Express Scripts lists three fill options: TRICARE home delivery, a network retail pharmacy, or a military pharmacy (MTF) that stocks weight-management drugs. Excluded groups (TRICARE For Life, direct-care-only, NATO/Partnership-for-Peace) cannot fill weight-loss drugs at a military pharmacy at all.
- Home delivery (mail order): up to a 90-day supply, lowest copay, shipped free. Best for an ongoing medication.
- Network retail pharmacy (CVS, Walgreens, Walmart, 60,000+ others): usually a 30-day supply, fast and local.
- Military (on-base) pharmacy: $0 for covered drugs — but call ahead; only some MTFs stock weight-management GLP-1s.
What should you do if TRICARE denies your GLP-1?
Don't treat every denial the same, and don't jump straight to paying cash. Read the denial, match it below, and you'll usually know your next move.
| What the denial says | What it usually means | PA form location | What to ask |
|---|---|---|---|
| "Coverage review required" | PA just hasn't been submitted | — | Ask your provider: which PA form did you send? |
| "Not covered for weight loss" | Wrong drug or excluded plan | Indication, Q5 | Confirm you're on Prime/Select and the drug is Wegovy/Zepbound/Saxenda |
| "Ozempic (or Mounjaro) denied" | No diabetes diagnosis or no metformin history | Diabetes criteria | Ask if it was submitted for diabetes with your metformin record |
| "Try a cheaper drug first" | Step-therapy trial isn't documented | Q15–Q20 | Ask if your chart shows the 3-month generic trial (or a contraindication) |
| "Prescriber not authorized" | Provider isn't network/MTF or didn't bill the visit | Q2 | Confirm a TRICARE network or MTF provider examined you and billed TRICARE |
| "BMI requirement not met" | BMI too low or missing a comorbidity | Q10 | Confirm your documented BMI (and a weight-related condition if 27–29) |
| "TFL no longer covered" | Weight-loss drug exclusion (Aug 2025) | TRICARE FAQ | Confirm whether your use is diabetes vs. weight-loss only |
| "Medical necessity required" | Drug is non-formulary or needs the MN form | — | Have your provider download the MN form from the Formulary Search Tool |
| "Renewal denied" | Approval expired or weight loss wasn't documented | Renewal Q33/Q35 | Ask if your renewal showed at least 5% weight loss since starting |
Call Express Scripts (877-363-1303) and say:
"I'm checking TRICARE coverage for [drug and strength] for [weight management / type 2 diabetes / sleep apnea]. Is it covered under my plan? Do I need prior authorization or a medical-necessity form? Which form should my provider use? Was my denial a clinical-criteria issue or a benefit exclusion? And where can I fill it?"
Then call your provider's office and say:
"Before we submit the prior authorization, can we confirm the exact drug, the diagnosis it's billed under, my BMI or diagnosis documentation, my prior medication history, my six-month diet record, and which TRICARE network pharmacy it goes to?"
Stuck in a denial loop?
Find My GLP‑1 Path →Maps your next step — fix the PA, switch drugs, or compare cash-pay.
What if you have TRICARE For Life?
Weight-loss GLP-1s (Wegovy, Zepbound, Saxenda) are no longer covered for TRICARE For Life members as of August 31, 2025 — even if you had an approval before. Diabetes GLP-1s (Ozempic, Mounjaro, Trulicity, Victoza) are still covered for type 2 diabetes with prior authorization.
- If it's for weight loss only: TRICARE For Life won't cover it.
- If it's for type 2 diabetes: the diabetes path is separate and still open.
- A possible Medicare angle: Because TRICARE For Life members are Medicare-eligible, there's a separate Medicare GLP-1 Bridge running July 1, 2026 through December 31, 2027. It covers Foundayo, Wegovy injection and tablets, and the Zepbound KwikPen for weight management at about $50/month. Two catches: you have to be enrolled in a Medicare Part D drug plan to use it, and most TRICARE For Life members rely on the TRICARE pharmacy benefit instead of Part D — so it won't apply automatically. Verify your Part D enrollment before counting on it.
What if TRICARE won't cover the GLP-1 you want?
First: is it actually a true "no"? Run through this fast:
- ?Was the right drug submitted (Wegovy/Zepbound for weight loss, not Ozempic/Mounjaro)?
- ?Are you on an eligible plan?
- ?Was the prior authorization actually filed and complete?
- ?Was a medical-necessity form needed?
- ?Was it sent to a network pharmacy?
Brand-name cash prices in 2026
| Brand-name drug (self-pay) | Typical 2026 cash price | List price for comparison |
|---|---|---|
| Wegovy injection (NovoCare) | ~$349/mo most doses; ~$199/mo intro for the two lowest doses (first 2 fills, through December 31, 2026) | ~$1,349/mo |
| Wegovy pill (NovoCare) | ~$149/mo for 1.5 mg and 4 mg (4 mg price runs through Aug. 31, 2026) | ~$1,349/mo |
| Zepbound (LillyDirect self-pay) | ~$299–$449/mo by dose; lowest maintenance price requires refilling within 45 days | ~$1,086/mo |
Cash prices and promos change often — reverify on NovoCare and LillyDirect before you buy.
A simpler cash-pay path: telehealth
If you'd rather not piece together a prescription and a pharmacy yourself, a telehealth program can bundle the visit, the prescription, and shipping. For FDA-approved brand-name GLP-1s, Ro is our pick for TRICARE members who've been excluded or don't want to fight the prior-authorization process.
What Ro costs: $39 for the first month, then as low as $74/month with an annual plan paid upfront (otherwise $149/month). The medication is billed separately at cash prices. Ro is a licensed, LegitScript-certified telehealth company that has operated since 2017 and prescribes FDA-approved brand-name medications only — no compounded drugs.
If TRICARE won't cover you and you want FDA-approved Wegovy or Zepbound without the prior-auth runaround:
See Ro's current self-pay pricing → (sponsored affiliate link, opens in a new tab)Sponsored affiliate link. Ro is cash-pay and does not bill TRICARE.
Want to compare options?
Sesame is a solid alternative for comparing branded options or Costco-member pricing. Visit sesamecare.com (sponsored affiliate link, opens in a new tab) to check current pricing (sponsored affiliate link).
Does TRICARE cover compounded semaglutide, the Wegovy pill, or Foundayo?
- Compounded GLP-1s: not verified as covered. Treat as cash-pay only.
- Wegovy pill: the weight-loss coverage path may apply, but confirm the exact formulary placement and copay on the Formulary Search Tool.
- Foundayo (orforglipron): very new. Verify current TRICARE status before counting on coverage. (It's also one of the drugs on the Medicare GLP-1 Bridge for weight management.)
When a drug is this new, the TRICARE Formulary Search Tool is the only source that's truly current — TRICARE updates its formulary every quarter.
How we verified this page
We built this guide straight from primary sources — official TRICARE coverage pages, the Express Scripts TRICARE pharmacy benefit, the live Wegovy/Zepbound prior-authorization form, the 2026 Defense Health Agency copay schedule, and the FDA. We used military forums only to understand how beneficiaries describe the frustration, never as a source for coverage or medical facts.
✅ What we actually verified (Last verified June 2026)
- TRICARE lists Wegovy, Saxenda, and Zepbound as weight-management drugs for eligible Prime/Select plans. (TRICARE.mil, Nov/Dec 2025)
- Trulicity, Ozempic, Mounjaro, and Victoza covered for type 2 diabetes. (TRICARE.mil, Aug 2025)
- TRICARE For Life, direct-care-only, and NATO/PfP members lost weight-loss coverage Aug 31, 2025.
- PA form (April 10, 2026): BMI thresholds, 6-month diet effort, 3-month step-therapy, Zepbound sleep-apnea path (AHI 15+, BMI 30+), 12-month initial approval, 5% renewal requirement.
- 2026 copays: $0 military; $44/$14 home delivery; $48/$16 retail; $0 active duty.
- FDA: 990 adverse events for compounded semaglutide, 730+ for tirzepatide (May 2026).
- Ro does not bill government insurance; TRICARE members may join cash-pay. (ro.co, 2026)
⚠️ Still smart to spot-check
- Your exact Formulary Search Tool result for your drug, strength, age, and plan.
- The exact copay tier (brand vs. non-formulary) for your specific drug.
- Current formulary status of the Wegovy pill and Foundayo.
- Any current Ro, NovoCare, or LillyDirect cash price (promos change).
Also see: Express Scripts + Zepbound coverage guide if your situation is specifically Zepbound and Express Scripts messaging.
Frequently asked questions
What GLP-1 does TRICARE cover for weight loss?
TRICARE covers Wegovy, Zepbound, and Saxenda for weight management for eligible Prime, Select, and premium-based plans, when you meet the clinical criteria and have an approved prior authorization. Ozempic and Mounjaro are not weight-loss coverage paths.
Does TRICARE cover Wegovy?
Yes, for weight management on eligible plans with prior authorization. The established path is the Wegovy injection; confirm the Wegovy pill's exact formulation and copay on the TRICARE Formulary Search Tool.
Does TRICARE cover Zepbound?
Yes, for weight management on eligible plans with prior authorization. Zepbound also has a separate coverage path for moderate-to-severe sleep apnea in adults with obesity, which requires a documented apnea-hypopnea index of 15 or higher and a BMI of 30 or higher.
Does TRICARE cover Ozempic for weight loss?
No. Ozempic is covered only for type 2 diabetes. For weight loss, the covered drugs are Wegovy or Zepbound.
Does TRICARE cover Mounjaro for weight loss?
No. Mounjaro is covered only for type 2 diabetes. Zepbound is the tirzepatide product TRICARE covers for weight management.
Does TRICARE cover Trulicity?
Yes, for type 2 diabetes. TRICARE notes it has a lower copay than Ozempic or Mounjaro, and its prior authorization can be waived if another diabetes drug is in your TRICARE record within the last 720 days.
Does TRICARE cover Rybelsus?
TRICARE has a prior-authorization path for Rybelsus (oral semaglutide) for adults with type 2 diabetes. Confirm current formulary status and copay on the Formulary Search Tool, since it isn't in TRICARE's main named examples.
Does TRICARE For Life cover GLP-1s for weight loss?
No. TRICARE For Life lost weight-loss drug coverage on August 31, 2025. Diabetes GLP-1 coverage still applies for type 2 diabetes.
Do I have to try a cheaper drug before Wegovy or Zepbound?
For weight loss, usually yes -- the form asks for about a three-month trial of a generic weight-loss pill (phentermine, phendimetrazine, diethylpropion, or benzphetamine) with under 5% weight loss, or a documented reason you can't take one. The Zepbound sleep-apnea path is an exception.
Can I fill Wegovy or Zepbound at a military pharmacy?
Sometimes. Express Scripts lists three fill options for approved weight-management GLP-1s: home delivery, a network retail pharmacy, and a military pharmacy that stocks weight-management drugs (call ahead). If you're in an excluded group -- TRICARE For Life, direct-care-only, or NATO/Partnership-for-Peace -- you can't fill weight-loss drugs at a military pharmacy at all.
Can I use a manufacturer savings card with TRICARE?
No. The $25 commercial copay cards from Novo Nordisk and Lilly exclude anyone enrolled in a government program, including TRICARE. Separate cash-pay purchase programs run on their own terms.
How long does TRICARE GLP-1 approval last?
The current Wegovy/Zepbound prior-authorization form approves initial therapy for 12 months, then requires annual renewal. Adults renewing the weight-loss path need to show at least 5% weight loss since starting.
Still not sure which GLP-1 program is right for you? Take our free 60-second matching quiz.
Find My GLP‑1 Path →Sources
- TRICARE — Does TRICARE cover Wegovy, Ozempic, and Mounjaro? (FAQ, updated Nov 2025)
- TRICARE — Weight Loss Products (updated Dec 2025)
- TRICARE Newsroom — TRICARE Coverage of Weight Loss Medications: What To Know (Aug 2025)
- TRICARE — Pharmacy Costs (2026-2027, updated April 2026)
- Express Scripts (TRICARE) — Are GLP-1 and weight loss medications covered?
- TRICARE Formulary Search Tool
- FDA — Zepbound approval for obstructive sleep apnea (Dec 2024)
- FDA — Concerns with Unapproved GLP-1 Drugs (updated June 2026)
- CMS — Medicare GLP-1 Bridge
- NovoCare — Wegovy cost & savings terms
- Ro (ro.co) — Weight loss pricing & insurance (verified 2026)
- MOAA — TRICARE GLP-1 coverage advocacy
The RX Index provides independent guidance for choosing your GLP-1 path. This page is educational and is not medical advice. Coverage rules change quarterly — confirm your specific drug and plan on the TRICARE Formulary Search Tool before making decisions.
Your situation changes the answer
Find My GLP-1 Path
The right GLP-1 provider isn't the same for everyone. It depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred route (injection or oral), and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized provider match with source-verified pricing before you choose.
- What it asks: your state, insurance situation, medication preference, budget, and support needs
- What you get: a personalized shortlist of GLP-1 providers matched to your situation, with verified pricing and the right questions to ask
- Cost: free · about 2 minutes · no signup